COLLEGIUM PHARMACEUTICAL, INC
COLL· Nasdaq· Pharmaceutical Preparations
- Market cap
- –
- P/FCF
- –
- EV/Sales
- –
- FCF margin
- 42.0%
- ROIC, 5 yr avg
- –
- Revenue, 5 yr CAGR
- +20.3%
We record prices for the companies we cover; COLL is not one of them yet.
Company statistics
Profile · FY2025
- Market cap
- –
- Enterprise value
- –
- Diluted shares
- 39.7M
- Revenue
- $780.6M
- Free cash flow
- $327.6M
- Owner earnings
- $285.7M
Valuation · FY2025
- P/E
- –
- P/FCF
- –
- P/Owner earnings
- –
- EV/Sales
- –
- EV/FCF
- –
- P/B
- –
Margins · FY2025
- Gross
- 59.3%
- Operating
- 23.0%
- Net
- 8.1%
- Free cash flow
- 42.0%
- Owner earnings
- 36.6%
- Stock pay
- 5.4%
Returns
- ROIC, FY2025
- 79.6%
- ROIC, 5 yr avg
- –
- ROE, FY2025
- 20.8%
- ROE, 5 yr avg
- 19.6%
Growth (CAGR)
- Revenue, 3 yr
- 18.9%
- Revenue, 5 yr
- 20.3%
- Revenue, 9 yr
- 97.5%
- Diluted EPS, 3 yr
- –
- Diluted EPS, 5 yr
- 17.9%
- Diluted EPS, 9 yr
- –
- Free cash flow, 3 yr
- 38.8%
- Free cash flow, 5 yr
- 30.0%
- Free cash flow, 9 yr
- –
Financial health · FY2025
- Cash and investments
- $386.7M
- Total debt
- $238.2M
- Net cash
- $148.5M
- Debt/Equity
- 0.8x
- Debt/FCF
- 0.7x
Shareholder returns · FY2025
- Dividend yield
- –
- Payout ratio
- –
- Buyback yield
- –
- Shareholder yield
- –
- Share count, 5 yr
- 2.5%
Financials: ten years from the 10-Ks
Revenue
$780.6M
+97.5% a year over 9 years
FY2016FY2025
Margins
Gross59.3%Operating23.0%Net8.1%
FY2025
FY2016FY2025
Free cash flow and owner earnings
Free cash flow$327.6MOwner earnings$285.7M
FY2025
FY2016FY2025
Diluted shares
39.7M
+20.5% over 9 years, net dilution
FY2016FY2025
Return on invested capital
79.6%
FY2025
FY2016FY2025
Net cash
$148.5M
$148.5M more cash than debt
FY2016FY2025
Every figure, year by year
| Fiscal year | FY2016 | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| The business | ||||||||||
| Revenue | $1.7M | $28.5M | $280.4M | $296.7M | $310.0M | $276.9M | $463.9M | $566.8M | $631.4M | $780.6M |
| Revenue growth | – | 1564.3% | 884.7% | 5.8% | 4.5% | -10.7% | 67.6% | 22.2% | 11.4% | 23.6% |
| Gross margin | – | – | 40.9% | 34.7% | 58.0% | 54.4% | 45.2% | 57.5% | 59.8% | 59.3% |
| Operating margin | -5498.7% | -264.9% | -7.4% | -8.0% | 18.1% | 6.4% | 7.2% | 29.5% | 26.9% | 23.0% |
| Net income | -$94.2M | -$74.9M | -$39.1M | -$22.7M | $26.8M | $71.5M | -$25.0M | $48.2M | $69.2M | $62.9M |
| Net margin | -5504.1% | -262.9% | -14.0% | -7.7% | 8.6% | 25.8% | -5.4% | 8.5% | 11.0% | 8.1% |
| Diluted EPS | – | – | $-1.19 | $-0.68 | $0.76 | $1.86 | $-0.74 | $1.29 | $1.86 | $1.73 |
| Return on invested capital? | – | – | – | – | 48.9% | – | – | 72.2% | 39.3% | 79.6% |
| Cash | ||||||||||
| Operating cash flow | -$75.1M | -$67.0M | $169.4M | $27.8M | $93.9M | $103.6M | $124.2M | $274.7M | $205.0M | $329.3M |
| Capital expenditure | $477.0K | $990.0K | $5.5M | $6.4M | $5.5M | $1.9M | $1.6M | $461.0K | $1.7M | $1.7M |
| Free cash flow | -$75.5M | -$68.0M | $163.9M | $21.3M | $88.4M | $101.6M | $122.6M | $274.3M | $203.3M | $327.6M |
| Stock-based compensation | $5.8M | $7.9M | $13.8M | $16.5M | $21.9M | $24.3M | $22.9M | $27.1M | $32.4M | $41.9M |
| Owner earnings? | -$81.3M | -$76.0M | $150.1M | $4.8M | $66.5M | $77.4M | $99.7M | $247.2M | $170.9M | $285.7M |
| Free cash flow per share | – | – | $4.97 | $0.64 | $2.51 | $2.48 | $3.62 | $6.56 | $5.03 | $8.25 |
| Capital allocation | ||||||||||
| Dividends paid | – | – | – | – | – | – | – | – | – | – |
| Share repurchases | – | – | – | – | – | $47.9M | $14.1M | $75.0M | $60.0M | $25.1M |
| Diluted shares | – | – | 33.0M | 33.5M | 35.2M | 41.0M | 33.8M | 41.8M | 40.4M | 39.7M |
| Share count change? | – | – | – | 1.5% | 5.1% | 16.8% | -17.6% | 23.5% | -3.3% | -1.8% |
| Balance sheet | ||||||||||
| Cash and equivalents | $153.2M | $118.7M | $146.6M | $170.0M | $174.1M | $186.4M | $173.7M | $238.9M | $70.6M | $231.3M |
| Short-term investments | – | – | – | – | – | – | – | $71.6M | $92.2M | $155.4M |
| Total debt | $4.1M | – | $11.5M | $11.5M | $99.6M | $140.0M | $140.9M | $262.1M | $237.2M | $238.2M |
| Net debt | -$149.1M | – | -$135.1M | -$158.5M | -$74.5M | -$46.5M | -$32.8M | -$48.4M | $74.4M | -$148.5M |
| Shareholders' equity | $134.9M | $104.1M | $91.6M | $87.4M | $186.0M | $202.9M | $194.8M | $195.4M | $228.8M | $301.7M |
Latest filings
| 2026-08-06 | 10-Q | Quarterly report |
| 2026-08-06 | 8-K | Earnings release |
| 2026-05-07 | 10-Q | Quarterly report |
| 2026-05-07 | 8-K | Earnings release |
| 2026-04-07 | DEF 14A | Proxy statement |
| 2026-02-26 | 10-K | Annual report |
| 2026-02-26 | 8-K | Earnings release |
| 2025-11-06 | 10-Q | Quarterly report |
| 2025-11-06 | 8-K | Earnings release |
| 2025-08-07 | 10-Q | Quarterly report |
More from our coverage
- MSFTPlatforms8.4MicrosoftThe most entrenched software franchise in the enterprise, now spending its cash flow on AI capacity; a great business we would own with a margin of safety, not at any price.Base value $410.29
- NVDAAI infrastructure8.4NVIDIAThe best business in technology at the top of its cycle: the moat is CUDA as much as silicon, but today's margins are a peak, not a floor.Base value $104.32
- AAPLHardware7.6AppleOne of the highest-quality businesses in the world growing in the low single digits; the price usually assumes more growth than the numbers show.Base value $134.27
- GOOGLPlatforms7.4AlphabetSearch pays for everything, and AI is both its biggest threat and its biggest opportunity; the price has to allow for search being worth less than it was.Base value $209.60
- NOWSoftware7.4ServiceNowA rare enterprise platform still growing above 20% with high retention; the free cash flow is real but stock pay takes a large share of it.Base value $189.13
- ADBESoftware7.4AdobeSuperb margins and a shrinking share count, priced for decline; the question is whether AI makes Adobe's tools more valuable or makes them unnecessary.Base value $449.35
